Young-Suk Lim

968 total citations
5 papers, 46 citations indexed

About

Young-Suk Lim is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Young-Suk Lim has authored 5 papers receiving a total of 46 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Hepatology and 1 paper in Infectious Diseases. Recurrent topics in Young-Suk Lim's work include Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Young-Suk Lim is often cited by papers focused on Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Young-Suk Lim collaborates with scholars based in South Korea. Young-Suk Lim's co-authors include Jae Il Kim, Jeong Heo, Yoon Jun Kim, Man‐Fung Yuen, David Mutimer, Sybil Tasker, Anna I. Bakardjiev, Won Young Tak, Tien Huey Lim and Pisit Tangkijvanich and has published in prestigious journals such as Journal of Hepatology and Cancer Research and Treatment.

In The Last Decade

Young-Suk Lim

4 papers receiving 44 citations

Peers

Young-Suk Lim

EPIDE

HEPAT

MB

IMMUN

ID

Taufique Ahmed Singapore

Alexandra Rohel France

Valerie Oberhardt Germany

Martin Graßhoff Germany

Felicity Hartnell Italy

Mirta Peralta Argentina

R. Balabanska Bulgaria

Sabine Preisler‐Adams Germany

Stephanie Buchholz Germany

Sylvia M. Brakenhoff Netherlands

Taufique Ahmed Singapore

Young-Suk Lim

83 ×1.9

EPIDE

68 ×2.0

HEPAT

9 ×0.7

MB

16 ×1.2

IMMUN

16 ×2.0

ID

Citations per year, relative to Young-Suk Lim Young-Suk Lim (= 1×) peers Taufique Ahmed

Countries citing papers authored by Young-Suk Lim

Since Specialization

Citations

This map shows the geographic impact of Young-Suk Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young-Suk Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young-Suk Lim more than expected).

Fields of papers citing papers by Young-Suk Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young-Suk Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young-Suk Lim. The network helps show where Young-Suk Lim may publish in the future.

Co-authorship network of co-authors of Young-Suk Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Young-Suk Lim. A scholar is included among the top collaborators of Young-Suk Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Young-Suk Lim. Young-Suk Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Jung, Jinhong, Jonggi Choi, Jin Hyoung Kim, et al.. (2025). Combined Transarterial Chemoembolization and External Beam Radiotherapy for Identifying Surgical Candidates for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: A Propensity Score–Weighted Analysis. Cancer Research and Treatment. 58(1). 275–283.

2.

Evans, Tom, Eleanor Barnes, Reena Mehta, et al.. (2023). Phase 1b/2a study of heterologous ChAdOx1-HBV/MVA-HBV immunotherapy (VTP-300) combined with low-dose nivolumab (LDN) in virally suppressed patients with CHB on nucleos (t)ide analogues. Journal of Hepatology. 78. S1169–S1170. 3 indexed citations

3.

Yuen, Man‐Fung, Edward Gane, Dong Joon Kim, et al.. (2020). RO7062931 antisense oligonucleotide phase 1 study demonstrates target engagement in patients with chronic hepatitis B on established nucleos(t)ide therapy. Journal of Hepatology. 73. S51–S51. 7 indexed citations

4.

Gane, Edward, Young-Suk Lim, Pisit Tangkijvanich, et al.. (2020). Preliminary safety and antiviral activity of VIR-2218, an X-targeting HBV RNAi therapeutic, in chronic hepatitis B patients. Journal of Hepatology. 73. S50–S51. 20 indexed citations

5.

Lim, Young-Suk, David Mutimer, Jeong Heo, et al.. (2019). PS-078-A phase 1b evaluation of HepTcell HBV-specific immunotherapy in nuc-controlled, eAg negative chronic HBV infection. Journal of Hepatology. 70(1). e50–e51. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact